2018 FDA Tides Harvest

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and econ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmaceuticals (Basel, Switzerland) Switzerland), 2019-04, Vol.12 (2), p.52
Hauptverfasser:	Al Shaer, Danah, Al Musaimi, Othman, Albericio, Fernando, de la Torre, Beatriz G
Format:	Artikel
Sprache:	eng
Schlagworte:	Binding sites Biological products dotatate Drugs FDA approval inotersen Liver Lutathera Molecular weight oligonucleotides Onpattro patisiran Peptides Pharmaceutical industry pharmaceutical market Proteins R&D Research & development Review Tegsedi
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
ISSN:	1424-8247 1424-8247
DOI:	10.3390/ph12020052